Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allograft mitral valve replacement.

Mark D. Plunkett1, Linda M. Bond, Dale M. Geiss

  • 1Division of Cardiovascular and Thoracic Surgery, University of Illinois College of Medicine, Peoria, IL.

Seminars in Thoracic and Cardiovascular Surgery. Pediatric Cardiac Surgery Annual
|August 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Surgical Approaches for Vascular-Related Aerodigestive Compression.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
Same journal

Transcatheter Interventional Options in Pulmonary Vein Stenosis: When to Stent?

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
Same journal

Airway Malacia: Stent Innovations and Emerging Ex Vivo Testing Platforms.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
Same journal

Bilateral Bronchus Suis Tracheoplasty.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
Same journal

Pulmonary Atresia With Major Aorto-Pulmonary Collateral Arteries (MAPCAs): Timing and Type of Intervention.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
Same journal

Pulmonary Atresia With Intact Ventricular Septum: Expert Review of the Surgical Management.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
See all related articles

Allograft mitral valve replacement (AMVR) shows promise for children and young adults, offering an alternative to mechanical or bioprosthetic valves. Early results suggest AMVR is a viable option, avoiding anticoagulation and preserving ventricular function.

Area of Science:

  • Cardiovascular Surgery
  • Transplantation Immunology
  • Pediatric Cardiology

Background:

  • Allograft valves have been used for cardiac valve replacement for over 40 years.
  • Early allograft mitral valve replacement (AMVR) failures were linked to preservation and implantation issues.
  • Advances in understanding mitral valve function, imaging, and preservation have renewed interest in AMVR.

Purpose of the Study:

  • To evaluate the efficacy and safety of allograft mitral valve replacement (AMVR) in pediatric and young adult patients.
  • To compare AMVR with bioprosthetic and mechanical valves in this demographic.
  • To highlight the benefits of AMVR, including avoidance of anticoagulation and preservation of subvalvar apparatus.

Main Methods:

  • Review of early clinical results of AMVR in eight children and young adults.

Related Experiment Videos

  • Inclusion of patients with diverse conditions: atrioventricular septal defects, prior mitral prosthesis, rheumatic disease, and endocarditis.
  • Assessment of early outcomes and comparison with existing valve replacement options.

    • Main Results:

    • Successful early results with AMVR were achieved in the studied pediatric and young adult cohort.
    • Allograft mitral valves offer advantages by avoiding anticoagulation and preserving ventricular function.
    • AMVR is presented as a potentially superior option compared to bioprosthetic and mechanical valves in this age group.

    Conclusions:

    • Early results suggest that allograft mitral valve replacement (AMVR) is a promising option for children and young adults.
    • AMVR provides significant benefits, including the avoidance of anticoagulation and preservation of subvalvar apparatus.
    • Further long-term follow-up is required to fully assess the durability and functional outcomes of AMVR in this population.